{"transactions":[{"id":933448,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-22T22:52:24.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 20, 2026, with the balance vesting thereafter in equal monthly installments over the next 36 months, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":350000,"derivative":{"exercise_price":1.12,"expiration_date":"2036-01-20","underlying":"Voting Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001193125-26-019729","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000119312526019729/ownership.xml","form_type":"4"}},{"id":1274085,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T22:47:29.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 3, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer."}],"balance_after":270000,"derivative":{"exercise_price":3.065,"expiration_date":"2035-01-03","underlying":"Voting Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0000950170-25-018120","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017025018120/ownership.xml","form_type":"4"}},{"id":1661954,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T21:21:56.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 29, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer."}],"balance_after":750000,"derivative":{"exercise_price":5.15,"expiration_date":"2034-01-31","underlying":"Voting Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0000950170-24-010522","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017024010522/ownership.xml","form_type":"4"}},{"id":1726720,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-30T17:00:11.000Z","date":"2023-11-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":20153,"price":0.9,"value":18137.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer to satisfy tax withholding obligations associated with the vesting and settlement of restricted stock units."}],"balance_after":202009,"source":{"system":"sec-edgar","filing":"0001209191-23-056981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000120919123056981/doc4.xml","form_type":"4"}},{"id":1728537,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-28T16:30:16.000Z","date":"2023-11-26","kind":"grant","planned":false,"acquired":true,"shares":125717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 50% of the RSUs shall vest on June 30, 2024, and the remaining 50% on December 31, 2024, in each case subject to the Reporting Person's continued service on such vesting date."}],"balance_after":222162,"source":{"system":"sec-edgar","filing":"0001209191-23-056802","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000120919123056802/doc4.xml","form_type":"4"}},{"id":1908176,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-02T16:45:09.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date."}],"balance_after":90000,"derivative":{"exercise_price":1.29,"expiration_date":"2033-04-28","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-23-026542","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000120919123026542/doc4.xml","form_type":"4"}},{"id":1950642,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-16T16:21:01.000Z","date":"2023-03-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, which is made as part of the Issuer's 2023 annual compensation cycle, vests and becomes exercisable in full on March 14, 2024."}],"balance_after":20000,"derivative":{"exercise_price":1.67,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-019289","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000120919123019289/doc4.xml","form_type":"4"}},{"id":2089571,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-12T16:25:17.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":2468,"price":1.93,"value":4763.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.85 to $2.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":5568,"source":{"system":"sec-edgar","filing":"0001209191-22-060691","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000120919122060691/doc4.xml","form_type":"4"}},{"id":2089570,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-12T16:25:17.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":3100,"price":1.69,"value":5239.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.78. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3100,"source":{"system":"sec-edgar","filing":"0001209191-22-060691","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000120919122060691/doc4.xml","form_type":"4"}},{"id":2101407,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-30T18:31:36.000Z","date":"2022-11-28","kind":"grant","acquired":true,"shares":90877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 50% of the RSUs shall vest on November 28, 2023, and the remaining 50% on November 28, 2024, in each case subject to the Reporting Person's continued service on such vesting date."}],"balance_after":90877,"source":{"system":"sec-edgar","filing":"0000899243-22-037232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000089924322037232/doc4.xml","form_type":"4"}},{"id":2151941,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-23T16:15:13.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on September 21, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":230000,"derivative":{"exercise_price":3.21,"expiration_date":"2032-09-21","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001209191-22-051131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000120919122051131/doc4.xml","form_type":"4"}},{"id":2432763,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-19T16:10:52.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in full on January 14, 2023."}],"balance_after":18500,"derivative":{"exercise_price":2.21,"expiration_date":"2032-01-14","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001209191-22-003701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000120919122003701/doc4.xml","form_type":"4"}},{"id":2903001,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-20T16:08:12.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in full on January 15, 2022."}],"balance_after":15000,"derivative":{"exercise_price":3.85,"expiration_date":"2031-01-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-004256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000120919121004256/doc4.xml","form_type":"4"}},{"id":3238013,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Stock Option (Right to buy)","published_at":"2020-03-02T19:27:48.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":45000,"derivative":{"exercise_price":8.87,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001562180-20-001935","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000156218020001935/primarydocument.xml","form_type":"4"}},{"id":3238012,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2020-03-02T19:27:48.000Z","date":"2020-02-28","kind":"sale","acquired":false,"shares":6976,"price":8.7,"value":60691.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019."}],"balance_after":144642,"source":{"system":"sec-edgar","filing":"0001562180-20-001935","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000156218020001935/primarydocument.xml","form_type":"4"}},{"id":3238011,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2020-03-02T19:27:48.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,500 shares of the Issuer's common stock purchased on June 28, 2019 and 1,500 shares of the Issuer's common stock purchased on December 31, 2019, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan."}],"balance_after":151618,"source":{"system":"sec-edgar","filing":"0001562180-20-001935","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000156218020001935/primarydocument.xml","form_type":"4"}},{"id":3324134,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-03T16:09:45.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in full on January 2, 2021."}],"balance_after":9000,"derivative":{"exercise_price":3.79,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-20-000814","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000120919120000814/doc4.xml","form_type":"4"}},{"id":3556595,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2019-04-12T16:00:29.000Z","date":"2019-04-11","kind":"disposition_to_issuer","acquired":false,"shares":13148,"price":7.7,"value":101239.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The proceeds from the disposition of these shares are to be used by the reporting person to cover tax liabilities associated with previously vested restricted stock units."}],"balance_after":118618,"source":{"system":"sec-edgar","filing":"0000899243-19-010587","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000089924319010587/doc4.xml","form_type":"4"}},{"id":3612128,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2019-03-05T16:06:09.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":7.28,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001562180-19-001675","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000156218019001675/primarydocument.xml","form_type":"4"}},{"id":3612127,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2019-03-05T16:06:09.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended.  One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 265 shares of the Issuer's common stock purchased under the Issuer's 2014 Employee Stock Purchase Plan on December 31, 2018."}],"balance_after":131766,"source":{"system":"sec-edgar","filing":"0001562180-19-001675","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000156218019001675/primarydocument.xml","form_type":"4"}},{"id":3675168,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-05T13:47:52.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in full on February 1, 2020."}],"balance_after":6000,"derivative":{"exercise_price":24.46,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-19-007236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000120919119007236/doc4.xml","form_type":"4"}},{"id":3732124,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2018-12-13T08:08:24.000Z","date":"2018-12-12","kind":"tax_withholding","acquired":false,"shares":22235,"price":8.94,"value":198780.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,500 shares acquired under the Akebia Therapeutics, Inc. stock purchase plan on June 29, 2018."}],"balance_after":66501,"source":{"system":"sec-edgar","filing":"0000899243-18-030789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000089924318030789/doc4.xml","form_type":"4"}},{"id":4019904,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2018-03-02T16:15:15.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan.  25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":27700,"derivative":{"exercise_price":14.3,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0001562180-18-001383","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000156218018001383/primarydocument.xml","form_type":"4"}},{"id":4019903,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2018-03-02T16:15:15.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total amount of beneficial securities owned includes 1,376 shares of stock purchased on June 30, 2017 at $8.92 per share and 723 shares of stock purchased on December 31, 2017 at $12.39 per share in connection with the Issuer's Employee Stock Purchase Plan."}],"balance_after":87236,"source":{"system":"sec-edgar","filing":"0001562180-18-001383","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000156218018001383/primarydocument.xml","form_type":"4"}},{"id":4190354,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2017-10-06T16:10:51.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve equal quarterly installments beginning on October 4, 2017."}],"balance_after":9000,"derivative":{"exercise_price":15.34,"expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001654954-17-009221","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000165495417009221/section16.xml","form_type":"4"}},{"id":4427652,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Stock Option (Right to buy)","published_at":"2017-02-23T16:01:40.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":47500,"price":10.14,"value":481650.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":47500,"derivative":{"exercise_price":0,"expiration_date":"2027-02-21","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0001562180-17-000878","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000156218017000878/primarydocument.xml","form_type":"4"}},{"id":4427651,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":69003,"kind":"person","name":"Amello Jason","position":1,"cik":"0001451805","reported_name":"Amello Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2017-02-23T16:01:40.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total amount of beneficial securities owned includes 1,500 shares of stock purchased on June 30, 2016 at $6.35 per share and 807 shares of stock purchased on December 31, 2016 at $6.48 per share in connection with the Issuer's Employee Stock Purchase Plan."}],"balance_after":65637,"source":{"system":"sec-edgar","filing":"0001562180-17-000878","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451805/000156218017000878/primarydocument.xml","form_type":"4"}}]}